Significados de lipid nanoparticle en inglés

Here, we describe methods for evaluating systemic delivery of miR-7 using a lipid nanoparticle formulation in an animal model.

The '069 patent relates to lipid nanoparticle (LNP) technology that allows the human body to make its own therapeutic proteins.

Low drug encapsulation efficiency and burst release are the main drawbacks of lipid nanoparticles.

The results after tail iv administration of oridonin and oridonin solid lipid nanoparticles were compared.

To solve these problems, lipid nanoparticles containing a cross-linked lipid network were prepared in this study.

The concentration-time curves of oridonin and oridonin solid lipid nanoparticles were both fitted to the three-compartment model.

Solid lipid nanoparticles were helpful for oridonin to reach a long circulation time and were hopeful to be its novel drug carrier.

The physicochemical properties of these lipid nanoparticles such as average diameter, drug loading, drug encapsulation efficiency and in vitro drug release were investigated.